Abbott Laboratories (ABT) Cash from Investing Activities (QoQ) (2009 - 2026)
Powered by 
Analysis
Abbott Laboratories (ABT) Cash from Investing Activities (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 177.93 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.70 Bn | 119.48 Bn | 1.96 Bn |
| 3 | Medtronic | 117.91 Bn | 109.09 Bn | 6.34 Bn |
| 4 | Stryker | 105.72 Bn | 102.25 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.52 Bn | 45.27 Bn | 1.35 Bn |
| 7 | Alcon | 33.89 Bn | 32.43 Bn | 1.68 Bn |
| 8 | Dexcom | 32.10 Bn | 30.15 Bn | 830.00 Mn |
| 9 | Steris | 21.06 Bn | 20.58 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.26 Bn | 17.85 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 96.69% |
| Mar 31, 2026 | -2,126.07% |
| Dec 31, 2025 | -99.78% |
| Sep 30, 2025 | 21.48% |
| Jun 30, 2025 | -23.83% |
| Mar 31, 2025 | 45.73% |
| Dec 31, 2024 | -45.79% |
| Sep 30, 2024 | -31.13% |
| Jun 30, 2024 | -6.59% |
| Mar 31, 2024 | 48.42% |
| Dec 31, 2023 | -29.97% |
| Sep 30, 2023 | 47.73% |
| Jun 30, 2023 | -162.55% |
| Mar 31, 2023 | 26.90% |
| Dec 31, 2022 | -30.58% |
| Sep 30, 2022 | -83.33% |
| Jun 30, 2022 | 26.67% |
| Mar 31, 2022 | 46.35% |
| Dec 31, 2021 | -3.07% |
| Sep 30, 2021 | -146.59% |